Galina Marder

1.3k total citations
26 papers, 706 citations indexed

About

Galina Marder is a scholar working on Epidemiology, Rheumatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Galina Marder has authored 26 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 11 papers in Rheumatology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Galina Marder's work include Inflammatory Myopathies and Dermatomyositis (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). Galina Marder is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (9 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Eosinophilic Disorders and Syndromes (5 papers). Galina Marder collaborates with scholars based in United States, Argentina and Netherlands. Galina Marder's co-authors include Maria-Louise Barilla-LaBarca, Steven B. Abramson, H. Michael Belmont, Jill P. Buyon, Richard Furie, Nina Kello, Diane Horowitz, Victor S. Martı́n, Robert M. Clancy and Sonali Narain and has published in prestigious journals such as Blood, CHEST Journal and Annals of the Rheumatic Diseases.

In The Last Decade

Galina Marder

24 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Galina Marder United States 11 341 219 216 116 98 26 706
Eduardo M. Acevedo‐Vásquez Peru 10 288 0.8× 128 0.6× 125 0.6× 57 0.5× 51 0.5× 20 665
M. Pérez-de-Lis Spain 17 411 1.2× 309 1.4× 242 1.1× 55 0.5× 54 0.6× 20 1.2k
Lieh-Bang Liou Taiwan 12 272 0.8× 233 1.1× 153 0.7× 73 0.6× 18 0.2× 34 550
Vincent Poindron France 17 376 1.1× 68 0.3× 291 1.3× 70 0.6× 49 0.5× 40 738
Luis Caminal‐Montero Spain 15 450 1.3× 90 0.4× 353 1.6× 122 1.1× 31 0.3× 68 762
E. Palazzo France 18 509 1.5× 107 0.5× 151 0.7× 111 1.0× 50 0.5× 49 888
Solange Grunenwald France 16 107 0.3× 127 0.6× 293 1.4× 134 1.2× 67 0.7× 49 922
Javier Merayo‐Chalico Mexico 16 308 0.9× 58 0.3× 314 1.5× 146 1.3× 47 0.5× 41 667
Francesca Li Gobbi Italy 13 312 0.9× 75 0.3× 231 1.1× 59 0.5× 50 0.5× 59 644
Ann Knight Sweden 17 337 1.0× 68 0.3× 207 1.0× 171 1.5× 32 0.3× 30 937

Countries citing papers authored by Galina Marder

Since Specialization
Citations

This map shows the geographic impact of Galina Marder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Galina Marder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Galina Marder more than expected).

Fields of papers citing papers by Galina Marder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Galina Marder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Galina Marder. The network helps show where Galina Marder may publish in the future.

Co-authorship network of co-authors of Galina Marder

This figure shows the co-authorship network connecting the top 25 collaborators of Galina Marder. A scholar is included among the top collaborators of Galina Marder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Galina Marder. Galina Marder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aggarwal, Rohit, Siamak Moghadam‐Kia, Sangmee Bae, et al.. (2025). Abatacept for the treatment of myositis-associated interstitial lung disease. Lara D. Veeken. 64(SI). SI156–SI168. 2 indexed citations
2.
3.
Narain, Sonali, et al.. (2024). The differential role of SSa/SSb and Ro52 antibodies in defining clinical phenotypes in idiopathic inflammatory myopathies. Seminars in Arthritis and Rheumatism. 65. 152407–152407. 5 indexed citations
4.
Aggarwal, Rohit, Siamak Moghadam‐Kia, Didem Saygın, et al.. (2023). POS1240 EFFICACY AND SAFETY OF ABATACEPT IN MYOSITIS ASSOCIATED INTERSTITIAL LUNG DISEASE. Annals of the Rheumatic Diseases. 82. 959–959. 2 indexed citations
5.
Marder, Galina, Tâm D. Quách, Jimmy S. H. Tsang, et al.. (2023). Belimumab treatment of adult idiopathic inflammatory myopathy. Lara D. Veeken. 63(3). 742–750. 15 indexed citations
6.
Saygın, Didem, Chester V. Oddis, Galina Marder, et al.. (2020). Follow-up results of myositis patients treated with H. P. Acthar gel. Lara D. Veeken. 59(10). 2976–2981. 8 indexed citations
7.
Giannis, Dimitrios, Steven L. Allen, Anne Davidson, et al.. (2020). Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry. Blood. 136(Supplement 1). 33–34. 5 indexed citations
8.
Narain, Sonali, Dimitre G. Stefanov, Andrew Weber, et al.. (2020). Comparative Survival Analysis of Immunomodulatory Therapy for Coronavirus Disease 2019 Cytokine Storm. CHEST Journal. 159(3). 933–948. 62 indexed citations
9.
Narain, Sonali, Dimitre G. Stefanov, Andrew Weber, et al.. (2020). Comparative Survival Analysis of Immunomodulatory Therapy for COVID-19 'Cytokine Storm': A Retrospective Observational Cohort Study. SSRN Electronic Journal. 5 indexed citations
10.
11.
Aggarwal, Rohit, et al.. (2017). Efficacy and safety of adrenocorticotropic hormone gel in refractory dermatomyositis and polymyositis. Annals of the Rheumatic Diseases. 77(5). 720–727. 37 indexed citations
12.
Agrawal, Abhinav, et al.. (2016). Biphasic flow-volume loop in granulomatosis with polyangiitis related unilateral bronchus obstruction. Respiratory Investigation. 54(4). 280–283. 5 indexed citations
13.
Barilla-LaBarca, Maria-Louise, et al.. (2011). Antisynthetase Syndrome. Current Rheumatology Reports. 13(3). 175–181. 116 indexed citations
14.
Marder, Galina, et al.. (2008). Prevalencia de leptospirosis en roedores sinantrópicos de la Ciudad de Corrientes, Argentina. Período mayo 2005–junio 2008. Revista Veterinaria. 19(2). 150–153. 3 indexed citations
15.
16.
Marder, Galina, et al.. (2005). Seroprevalencia de brucelosis en hemodonantes del Banco de Sangre de Corrientes, Argentina. Revista Veterinaria. 16(2). 61–64. 2 indexed citations
17.
Marder, Galina, et al.. (2004). Infestación parasitaria en suelos y materia fecal de perros y gatos de la ciudad de Corrientes. Revista Veterinaria. 15(2). 70–72. 4 indexed citations
18.
Ahmed, Shahid, et al.. (2002). Severe Upper Airway Obstruction From Cricoarytenoiditis as the Sole Presenting Manifestation of a Systemic Lupus Erythematosus Flare. CHEST Journal. 121(3). 990–993. 24 indexed citations
19.
Clancy, Robert M., Galina Marder, Victor S. Martı́n, et al.. (2001). Circulating activated endothelial cells in systemic lupus erythematosus: Further evidence for diffuse vasculopathy. Arthritis & Rheumatism. 44(5). 1203–1208. 96 indexed citations
20.
Marder, Galina, et al.. (1990). Toxoplasma infection rate in man in relation to those in dogs and cats in Corrientes City.. 7(68). 518–522. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eduardo M. Acevedo‐Vásquez Breakdown of academic impact, for papers by M. Pérez-de-Lis Breakdown of academic impact, for papers by Lieh-Bang Liou Breakdown of academic impact, for papers by Vincent Poindron Breakdown of academic impact, for papers by Luis Caminal‐Montero Breakdown of academic impact, for papers by E. Palazzo Breakdown of academic impact, for papers by Solange Grunenwald Breakdown of academic impact, for papers by Javier Merayo‐Chalico Breakdown of academic impact, for papers by Francesca Li Gobbi Breakdown of academic impact, for papers by Ann Knight
Rankless by CCL
2026